Preventive Vaccines Market 2021


Roots Analysis

<b>Roots Analysis is pleased to announce the publication of its recent study, titled, “Global </b>Preventive Vaccines Market , 2021-2030”.

<b>The report features an extensive study of the current market landscape and future opportunities associated with the preventive vaccine domain. The study also features a detailed analysis of the key drivers and trends related to this evolving segment of the pharmaceutical industry. Amongst other elements, the report includes: </b>

· A detailed assessment of the current market landscape, featuring clinical-stage preventive vaccines.

· A competitiveness analysis of preventive vaccine developers, featuring insightful pictorial summaries and representations.

· Elaborate profiles of the key preventive vaccine developers (shortlisted based on a proprietary criterion) across North America, Europe and Asia Pacific.

· An in-depth analysis of the completed, ongoing and planned trials of various preventive vaccines.

· An overview of the ongoing vaccine development initiatives for complex conditions, such as COVID-19, Ebola virus disease, HIV/AIDS, malaria and zika virus infection.

· An analysis of the investments made in this domain, during the period between 2015 and 2020 (till March).

· A case study on contract manufacturing landscape for vaccines, featuring the CMOs engaged in this domain.

<b>Know more: </b>

<b>A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)</b>

<b>Route of Administration</b>

· Intramuscular

· Subcutaneous

· Oral

· Intravenous

· Others

<b>Type of Vaccine</b>

· Pneumococcal Conjugate Vaccine

· Human Papilloma Virus Vaccine

· Rotavirus Vaccine

· Influenza Vaccine

· MMR Vaccine

· Tetanus and Diphtheria Booster Vaccine

· Varicella Vaccine

· DTaP-Hib-IPV Vaccine

· DTaP-HepB-Hib-IPV Vaccine

· Others

<b>Get an Exclusive Sample PDF @ </b>

<b>Type of Vaccine API</b>

· Live, Attenuated Vaccine

· Inactivated Vaccine

· Conjugate Vaccine

· Subunit Vaccine

· Toxoid Vaccine

· Others

<b>Target Patient Population</b>

· Pediatric Patients

· Adults

<b>Key Players</b>

· GlaxoSmithKline

· Merck

· Sanofi Pasteur

· Pfizer

· Emergent BioSolutions


· Others

<b>Key Geographical Regions </b>

· North America

· Europe

· Asia Pacific

· Rest of the World

<b>Key companies covered in the report</b>

· Bio Farma

· Emergent BioSolutions

· GC Pharma

· GlaxoSmithKline

· Janssen

· Merck

· Novavax

· Pfizer

· Sanofi Pasteur

· Valneva

<b>Table of Contents</b>

1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape

5. Company Competitiveness Analysis

6. Company Profiles

7. Clinical Trial Analysis

8. Ongoing Vaccine Development Initiatives for Complex Conditions

9. Funding and Investment Analysis

10. Market Sizing and Opportunity Analysis

11. Case-in-Point: Contract Manufacturing of Vaccines

12. Concluding Remarks

13. Executive Insights

14. Appendix 1: Tabulated Data

15. Appendix 2: List of Companies and Organizations

<b>Enquiry Before Purchase: </b>    

<b>Also Visit Our Latest Publication</b>

Human Microbiome Market

<a href="">In Silico / Computer-Aided Drug Discovery Services Market</b></a>

Antibody Contract Manufacturing Market

Biopharma Contract Manufacturing Market

Cell Therapy Manufacturing Market


PopularIn orderChat mode

No replies yet

Be the first one to reply to wilsonstella522

Joined discussion